Immunological, antioxidative, and morphological response in combined treatment of ofloxacin and Lactobacillus fermentum ME-3 probiotic in Salmonella Typhimurium murine model

APMIS

Volumn 118, Issue 11, 2010, Pages 864-872

  Truusalu, Kai ^a   Kullisaar, Tiiu ^b   Hütt, Pirje ^a   Mahlapuu, Riina ^b   Aunapuu, Marina ^c   Arend, Andres ^c   Zilmer, Mihkel ^b   Mikelsaar, Raik Hiio ^a   Mikelsaar, Marika ^a  

^a Institutes of Microbiology   (Estonia)

^b Institutes of Biochemistry   (Estonia)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

Biochemical response; Immunological; Lactobacillus fermentum ME 3; Murine model; Salmonella typhimurium

Indexed keywords

GAMMA INTERFERON; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 10; LIPID PEROXIDE; OFLOXACIN; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG POTENTIATION; ILEUM; INTESTINE MUCOSA; LACTOBACILLUS FERMENTUM; LIPID PEROXIDATION; LIVER; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SALMONELLA ENTERICA; SMALL INTESTINE; SPLEEN; TISSUE LEVEL; TYPHOID FEVER; ANIMAL; DISEASE MODEL; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PARATYPHOID FEVER; PHYSIOLOGY; SALMONELLA TYPHIMURIUM; STATISTICAL MODEL;

ANIMALS; ANTI-BACTERIAL AGENTS; CYTOKINES; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; LACTOBACILLUS FERMENTUM; LIPID PEROXIDES; LIVER; LOGISTIC MODELS; MALE; MICE; OFLOXACIN; PARATYPHOID FEVER; PROBIOTICS; SALMONELLA TYPHIMURIUM; SPLEEN;

EID: 78149265618     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02672.x     Document Type: Article

References (33)

1. Huang DB, DuPont HL. Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection. Lancet Infect Dis. 2005;5:341-8.
2. Basnyat B, Maskey AP, Zimmerman MD, Murdoch DR. Enteric (typhoid) fever in travelers. Clin Infect Dis 2005;41:1467-72.
3. Mert A, Tabak F, Ozaras R, Ozturk R, Aki H, Aktuglu Y. Typhoid fever as a rare cause of hepatic, splenic, and bone marrow granulomas. Intern Med 2004;43:436-9.
4. Santos RL, Zhang S, Tsolis RM, Kingsley RA, Adams LG, Baumler AJ. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect 2001;3:1335-44.
5. Stecher B, Hardt WD. The role of microbiota in infectious disease. Trends Microbiol 2008;16:107-14.
6. Truusalu K, Mikelsaar RH, Naaber P, Karki T, Kullisaar T, Zilmer M, et al. Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiol 2008;8:132.
7. FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. London, Ontario: Food and Agriculture Organization of United Nations and World Health Organization, Working Group Report, 2002 [cited]. Available from:
8. Songisepp E, Kals J, Kullisaar T, Mandar R, Hutt P, Zilmer M, et al. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr J 2005;4:22.
9. Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol 2004;70:3189-94.
10. Ben Amor K, Vaughan EE, De Vos WM. Advanced molecular tools for the identification of lactic acid bacteria. J Nutr 2007;137(3 Suppl 2):741S-7S.
11. Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004;53:1602-9.
12. Stagg AJ, Hart AL, Knight SC, Kamm MA. Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. Best Pract Res Clin Gastroenterol 2004;18:255-70.
13. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 2001;73(2 Suppl):444S-50S.
14. Smits HH, Engering A, Van Der Kleij D, De Jong EC, Schipper K, Van Capel TM, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005;115:1260-7.
15. Diaz-Ropero MP, Martin R, Sierra S, Lara-Villoslada F, Rodriguez JM, Xaus J, et al. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol 2007;102:337-43.
16. Marcinkiewicz J, Ciszek M, Bobek M, Strus M, Heczko PB, Kurnyta M, et al. Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int J Exp Pathol 2007;88:155-64.
17. Mikelsaar M, Zilmer M, Kullisaar T, Annuk H, Songisepp E. Strain of micro-organism Lactobacillus fermentum ME-3 as novel anti-microbial and anti-oxidative probiotic, 2007; USA patent number US 7244424.
18. Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, et al. Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol 2002;72:215-24.
19. Annuk H, Shchepetova J, Kullisaar T, Songisepp E, Zilmer M, Mikelsaar M. Characterization of intestinal lactobacilli as putative probiotic candidates. J Appl Microbiol 2003;94:403-12.
20. Mikelsaar M, Zilmer M. Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic. Microb Ecol Health Dis 2009;21:1-27.
21. Fu KP, Hilliard J, Isaacson D, Tobia AJ, Rosenthale ME, McGuire JL. In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice. J Antimicrob Chemother 1990;25:263-8.
22. Sneller MC. Granuloma formation, implications for the pathogenesis of vasculitis. Cleve Clin J Med 2002;69(Suppl 2):SII40-3.
23. Gill HS. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2003;17:755-73.
24. Maassen CB, Van Holten-Neelen C, Balk F, Den Bak-Glashouwer MJ, Leer RJ, Laman JD, et al. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000;18:2613-23.
25. Wickham ME, Brown NF, Provias J, Finlay BB, Coombes BK. Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain. BMC Infect Dis 2007;7:65.
26. Mittrucker HW, Raupach B, Kohler A, Kaufmann SH. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol 2000;164:1648-52.
27. Sashinami H, Yamamoto T, Nakane A. The cytokine balance in the maintenance of a persistent infection with Salmonella enterica serovar Typhimurium in mice. Cytokine 2006;33:212-18.
28. Murata Y, Shimamura T, Hamuro J. The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 2002;14:201-12.
29. Hutt P, Shchepetova J, Loivukene K, Kullisaar T, Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol 2006;100:1324-32.
30. Truusalu K, Naaber P, Kullisaar T, Tamm H, Mikelsaar R-H, Zilmer K, et al. The influence of antibacterial and antioxidative probiotic lactobacilli on gut mucosa in a mouse model of Salmonella infection. Microb Ecol Health Dis 2004;16:180-7.
31. Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, Germain RN. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 2008;28:271-84.
32. Dogi CA, Galdeano CM, Perdigon G. Gut immune stimulation by non pathogenic Gram(+) and Gram(-) bacteria. Comparison with a probiotic strain. Cytokine 2008;41:223-31.
33. Annuk H, Hynes SO, Hirmo S, Mikelsaar M, Wadstrom T. Characterisation and differentiation of lactobacilli by lectin typing. J Med Microbiol 2001;50:1069-74.